The University of Pittsburgh is launching a startup business accelerator called LifeX, backing a push to leverage Western Pennsylvania’s strengths in the life sciences with private investors.

The new center will be located in the Strip District and 10 companies have committed to moving in, including Sharp Edge Labs Inc., Western Oncolytics Ltd. and Peptilogics Inc.

Dietrich Stephan, a serial entrepreneur and chair of Pitt’s Department of Human Genetics, will serve as LifeX CEO.

“This is an enormous opportunity we’re sitting on,” Pitt Chancellor Patrick Gallagher said at a Monday morning conference in Oakland to discuss the initiative. “We are sitting on a treasure trove of opportunities.”

Advertise with us

The accelerator — a place where promising startup life science companies receive guidance and funding — will be operational by March 1 and have an early stage investment fund of $25 million for startups in the accelerator’s laboratory facilities.

A national fundraising effort is underway for the fund, which is expected to close in summer.

LifeX will also have a larger, later-stage investment fund, but the amount hasn’t been determined. The 10-year goal of the project is to foster development of pharmaceutical products and medical devices that address cancer, Alzheimer’s disease and multidrug-resistant bacterial infections among other issues.

Kris B. Mamula: kmamula@post-gazette.com or 412-263-1699